SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-035513
Filing Date
2020-02-13
Accepted
2020-02-13 16:02:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d858306dsc13g.htm SC 13G 37073
  Complete submission text file 0001193125-20-035513.txt   38516
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Subject) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88050 | Film No.: 20610306
SIC: 2834 Pharmaceutical Preparations

Mailing Address 360-1616 EASTLAKE AVENUE E. SEATTLE WA 98102
Business Address
Ulge Umut (Filed by) CIK: 0001803049 (see all company filings)

Type: SC 13G